SoloHealth Receives FDA Approval of its SoloHealth Station

ATLANTA— SoloHealth, a leading consumer-driven health care technology company, has received approval from the U.S. Food and Drug Administration (FDA) for its next-generation SoloHealth Station, an interactive, comprehensive health and wellness screening kiosk for consumers.

Currently in select U.S. test markets and retail locations, SoloHealth is launching an aggressive national rollout of the SoloHealth Station, projecting thousands of kiosks will be in retail pharmacy locations nationwide by end of the year. Executives expect to announce partnerships with key retailers and strategic alliances within the next 30 to 60 days as they ramp up for expansion.

The SoloHealth Station provides health screenings for vision, blood pressure, weight, and body mass index, a symptom checker as well as an overall health assessment free of charge. SoloHealth also helps connect consumers to local professionals through their databases. The news comes on the heels of the FDA exploring the use of kiosks in pharmacies to educate, self-diagnose and dispense prescription drugs for certain chronic conditions, SoloHealth’s statement noted.

"We hold accuracy, reliability, and safety standards at the highest level and are pleased to have met and exceeded regulatory standards with the testing trials we have conducted nationwide," said Stephen Kendig, COO of SoloHealth. "With the FDA clearance, we can now aggressively begin our nationwide rollout of the SoloHealth Station, providing consumers free access to their health data in convenient retail locations across the U.S. We believe our SoloHealth Station will help educate and empower millions of Americans to take charge of their own health and should ultimately lead to a healthier, more efficient, and more financially sound nationwide health care system."

The SoloHealth Station was recently honored with Intel's IT health care award, the "Intel Innovation Award," that recognizes leading-edge technology and exceptional innovation for health care delivery and processes. The company's award-winning first offering was the EyeSite Vision kiosk. In summer 2010, the company received a $1.2 million grant from the National Institute of Health (NIH), a division of the U.S. Department of Health and Human Services, to help enable innovation for self-service health care and prevention. In 2011, SoloHealth announced its next-generation kiosk, the SoloHealth Station. The company's bilingual kiosks provide free health screenings and recommendations for follow-up care, which leads to prevention and lower health care costs. In March 2011, Coinstar, Inc., owner of Redbox, made a financial investment in SoloHealth.

SoloHealth’s founder and CEO, Bart Foster, was a featured speaker on the rise of self-service healthcare trends at this year’s Vision Monday’s Global Leadership Summit.